Your session is about to expire
← Back to Search
Exercise Program for Type 2 Diabetes
Study Summary
This trial will study how diabetes affects the muscle, and if exercise can help improve symptoms. They will use MRI to measure muscle stiffness, strength, and function.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of alcoholism, drug use, or chronic issues with my stomach, kidneys, or liver.I am between 40 and 75 years old.I do not have any open wounds or a history of foot ulcers in the last 3 months.I have had part of my foot amputated.I am not pregnant and I am not a child.I have been diagnosed with Type 2 diabetes.I cannot have an MRI due to a pacemaker, metal implants, or severe claustrophobia.I need help to walk, like a cane or walker.I have heart or muscle issues that limit my ability to exercise.My BMI is under 40.I have had a stroke or another brain condition.My blood pressure is often above 160/100.I can walk by myself without help.
- Group 1: Exercise Program Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What goals has this research endeavor been designed to accomplish?
"During a Week 1 to Week 11 time period, researchers will record the alteration in calf muscle strength as their primary outcome. The number of participants with neuropathy (as determined by Michigan Neuropathy Screening Instrument), osteoarthritis (based on American College of Rheumatology Clinical Classification Criteria) and adherence to an exercise program (with <20% attrition and >75% attendance levels expected for those with Type 2 diabetes Mellitus) are also tracked as secondary outcomes."
Are any participants currently being enrolled for this trial?
"According to information on clinicaltrials.gov, this trial is presently enrolling participants and has been since its initial posting date of September 1st 2021 with the most recent update occurring on April 20th 2022."
How many participants have joined this experiment?
"Affirmative. Clinicaltrials.gov's records allude to this clinical trial, initially posted on September 1st 2021, still being open and searching for participants. Specifically, 30 patients are sought after across one site of recruitment."
Does this trial offer enrollment for individuals of advanced age?
"This clinical trial is specifically seeking patients between the ages of 40 and 75. For those younger than 18 years old, there are 193 studies available; similarly for seniors aged 65 or above, 1,105 other trials exist."
Who has the qualifications to register for this medical trial?
"This scientific trial is seeking 30 individuals with type 2 diabetes mellitus around the ages of 40 and 75. Eligible candidates must meet certain criteria, such as: a BMI below 40 kg/m2 (limited by magnet bore size), capable of independent locomotion, and age between 40 to 75 years old."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger